When managing stable broad regular tachyarrhythmia, what is the initial dose of Amiodarone for urgent treatment?

In the management of stable broad regular tachyarrhythmia, the initial treatment with Amiodarone is to administer 150 mg intravenously. This dosage is correct as it demonstrates the standard initial dose recommended for urgent treatment of such conditions.

Amiodarone is an antiarrhythmic medication that is effective in the control of various types of tachyarrhythmias, including ventricular tachycardia and supraventricular tachycardia. The initial dosing is set at 150 mg in a rapid infusion over 10 minutes, which allows for effective drug levels to be achieved quickly while minimizing potential side effects associated with higher doses.

Administering higher doses, such as 300 mg or more, is not advisable in this initial phase as it does not align with the established protocols. The noted 150 mg dose serves as a starting point, allowing for further treatment adjustments based on the patient's response and clinical condition. Thus, the choice of 150 mg is grounded in both efficacy and safety considerations for urgent treatment.